{
  "id": 15765909,
  "title": "Excellent 10-Year Outcomes After Early Treat-to-Target in Rheumatoid Arthritis",
  "url": "https://urgent.news/2026/10/20/excellent-10-year-outcomes-after-early-treat-to-target-in-rheumatoid",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-20T15:23:54.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/rheumatology/arthritis/123477"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- Most patients with rheumatoid arthritis (RA) whose initial treatment used a stringent treat-to-target strategy in a clinical trial were in remission 10 years later, with only modest radiographic progression over that time, researchers...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}